In patients with cystic fibrosis (CF), the chronic colonization of the airways with Pseudomonas aeruginosa is a major cause for morbidity and mortality (2, 7) . Once this opportunistic pathogen has chronically colonized the patient's lungs, it is virtually impossible to eradicate the organism by antimicrobial chemotherapy (2, 7) . So far, only a few groups have addressed the problem of nosocomial acquisition of P. aeruginosa in CF patients (4, 8-10, 12, 14, 17-19, 21, 24) . In contrast to the Danish experience (9, 14, 24) , most investigations of CF patients attending summer camps (10, 19, 21) and sharing hospital rooms (17) have failed to demonstrate any cross colonization. These data, however, may be biased by the short observation periods of less than a month, in which a slowly growing epidemic would have escaped notice. Hoiby and Pedersen calculated the risk of cross infection to increase with "contact density," i.e., the number of days a noninfected CF patient spent at a CF center (8) . The Danish group observed that the yearly incidence of P. aeruginosa acquisition at their clinic had been increased during a period when there were more CF patients and their visits to the clinic were more frequent and that it had finally dropped from 17 to 3% after infected and noninfected CF patients were separated (8) . Moreover, when the prevalence of chronic P. aeruginosa infection was compared for various CF centers, the percentage of patients colonized was found to be positively correlated with the population size (8 4) and DraI (lanes 6 through 9) digests of chromosomes of strains (from left to right) CF10839, CF89839, CF99839, and CF121838 were separated on 1% agarose gels by field inversion gel electrophoresis. X oligomers as size markers (monomer, 48.5 kbp) were applied to lanes 5 and 10. Electrophoresis was run for 20 h at 14C with a field strength of 5.6 V/cm. Pulse times were increased linearly from 1 to 30 s; the forward-to-reverse ratio was chosen to be 3:1. All strains were 0 serotype 4 and pyocin type lh and had the phage lysis pattern PS31, M4, F8, PS24, P82. VOL. 29, 1991 Nosocomial acquisition at CF recreation camps, rehabilitation centers, and clinics could be demonstrated for 12 cases. In order to limit the burden of nosocomial infection in the patient population, hygienic precautions were introduced at the CF clinic by May 1986. Infected and noninfected patients were hospitalized in separate wards. CF patients were not allowed to share rooms and were kept isolated if they were diagnosed with antibiotic-resistant P. aeruginosa strains. After discharge of the patients, the water taps and sinks in the patients' rooms were disinfected. During the next 2 years, only a single episode of nosocomial transmission was detected: two patients in the CF ward picked up an identical P. aeruginosa strain that neither of them had had previously.
At the outpatient clinic, all patients continued to be seen in the same rooms, but infected and noninfected patients were separated for lung function testing and lessons in physiotherapy. The hands of medical personnel were examined for contamination with pseudomonads by the infection control nurse. By 1988, all unrelated CF patients were found to carry different P. aeruginosa strains, whereas mutual exchange of strains continued in families with two or more children with CF. Hence, the hygienic measures at the clinic seemed to be effective.
The data of this retrospective study confirm the conclusion of the Danish group (8) that nosocomial transmission contributes to a significant extent to the prevalence of P. aeruginosa in CF populations. During the last decade, another Pseudomonas species, P. cepacia, has become a serious problem in several CF centers in England (16) and North America (11, 22) . Person-to-person transmission of this pathogen among CF patients was demonstrated by ribotyping of the isolates (13) . By employing highly discriminatory DNA-based typing techniques such as Southern analysis of hypervariable sites (13, 23) and genome fingerprinting (reference 4 and this work), the more recent studies all demonstrate the communicability of Pseudomonas infections in patients with CF. Hence, avoidable social exposure of noninfected CF patients to P. aeruginosa-or P. cepaciapositive CF patients should be carefully evaluated on a case-to-case basis in order to minimize the risk of cross infection.
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